Aarti Industries announced the successful commissioning of Phase I of its Zone IV project at Jhagadia, Gujarat, marking an important milestone in the company's ongoing growth and expansion journey. According to reports from Business Standard, this development brings together multiple chemical manufacturing capabilities under one platform.
Phase I includes Calcium Chloride, PEDA (2-Phenyl Ethyl Diethyl Aniline) and a part of its Multipurpose Plant (MPP). As reported by Business Standard, these facilities create complementary capabilities in downstream integration, diversified end-use applications, and flexible multi-product manufacturing. The platform is designed to support the commercialisation of high-value and niche products, with several products planned from Zone IV expected to be manufactured in India for the first time.
PEDA extends AIL's existing Ethylation platform further downstream, building on the company's established 2,6-Diethyl Aniline capabilities and strengthening its participation in value-added products catering primarily to agrochemical applications. According to Business Standard, the Calcium Chloride facility strengthens AIL's Energy & Additives portfolio with applications across sectors including oilfield and energy-related markets. The Multipurpose Plant provides a flexible manufacturing platform to scale pilot-validated processes into commercial production across multiple products and advanced chemistries.
With Phase I commissioning now completed, Aarti Industries' focus will progressively shift towards commercial qualification, customer approvals and disciplined ramp-up of the newly commissioned assets, as reported by Business Standard. This strategic approach ensures proper validation and market readiness for the newly established manufacturing capabilities.
